EUVIMEDEUVIMED entdecken
Crossref

Glycome remodeling programs pathogenic γδ T17 cell responses in autoimmunity

Beatriz Santos-Pereira iD, Rafaela Nogueira iD, Yohannes Tafesse iD, Ariana Correia-Silva iD, Eduarda Leite-Gomes iD, Guillem Sanchez Sanchez iD, Xavier Luppens iD, Lyndsay E A Young iD, Bruno Cavadas, Carlos Vasconcelos iD, Daniela Oliveira iD, Ana Lé iD und 10 weitere

Science Immunology · 2026

DOI: 10.1126/sciimmunol.aec9553 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science Immunology, 2026. Verfasst von Beatriz Santos-Pereira und 21 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Research and Innovation in Health, University of Porto, Porto, Portugal. Hauptthemen laut MEDLINE: Autoimmunity, Receptors, Antigen, T-Cell, gamma-delta, Polysaccharides. Die Arbeit nennt 78 Literaturangaben. Gefördert von: National Institute of Diabetes and Digestive and Kidney Diseases, H2020 European Research Council, Lupus Research Alliance.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Glycans play fundamental roles in T cell biology; however, the glycome landscape of γδ T cells remains to be unlocked. Despite the growing importance of γδ T cells in host defense, tissue homeostasis, and diseases, the glycosylation mechanisms guiding their activation, commitment, and function remain poorly defined. By performing single-cell RNA sequencing, we revealed that type 3/γδ T17/interleukin-17A (IL-17A)–committed γδ T cells rely on ( N-acetylglucosaminyltransferase 1 ) MGAT1 – MGAT5 –mediated branched N-glycosylation. We further demonstrated that the absence of branched N -glycans on γδ T cells acts as a peripheral signal, driving an IL-17A–pro-inflammatory phenotype, alongside a shift to a Vγ4 + subset and the imprinting of innate-like properties. This altered glycoform of type 3 γδ T cells was shown to induce severe psoriasis. γδ T cells from patients with autoimmune and inflammatory diseases exhibited a deficiency in branched N -glycans. Glycan supplementation can reprogram γδ T cells toward a less-pathogenic state, highlighting N -glycans as a previously unrecognized immune checkpoint for γδ T cells.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AutoimmunityReceptors, Antigen, T-Cell, gamma-deltaPolysaccharidesAnimalsHumansInterleukin-17N-AcetylglucosaminyltransferasesMiceGlycosylationPsoriasis

Substanzen

Receptors, Antigen, T-Cell, gamma-deltaInterleukin-17N-AcetylglucosaminyltransferasesPolysaccharides

Autor:innen und Institutionen

  • Institute for Research and Innovation in Health, University of Porto, Porto, Portugal.
  • Faculty of Medicine, University of Porto, Porto, Portugal.
  • School of Medicine and Biomedical Sciences, University of Porto, Porto, Portugal.
  • Department of Pharmacotherapy and Pharmaceutics, Université Libre de Bruxelles, Brussels, Belgium.
  • Institute for Medical Immunology, Université Libre de Bruxelles, Gosselies, Belgium.
  • Center for Research in Immunology, Université Libre de Bruxelles, Brussels, Belgium.

ORCID-Profile: Beatriz Santos-Pereira, Rafaela Nogueira, Yohannes Tafesse, Ariana Correia-Silva, Eduarda Leite-Gomes, Guillem Sanchez Sanchez, Xavier Luppens, Lyndsay E A Young, Carlos Vasconcelos, Daniela Oliveira, Ana Lé, Joana Torres, Ana Campar, António Marinho, José D Alves, Richard R Drake, David Vermijlen, Inês Alves, Salomé S Pinho

Förderung

  • National Institute of Diabetes and Digestive and Kidney Diseases
  • H2020 European Research Council
  • Lupus Research Alliance
  • Fundação para a Ciência e a Tecnologia
  • European Society for Clinical Investigation
  • European Federation of Immunological Societies
  • Université Libre de Bruxelles
  • European Union

Zitieren

APA

Santos-Pereira, B., Nogueira, R., Tafesse, Y., Correia-Silva, A., Leite-Gomes, E., Sanchez Sanchez, G., Luppens, X., Young, L. E. A., Cavadas, B., Vasconcelos, C., Oliveira, D., Lé, A., Torres, J., Campar, A., Serodio, J. F., Marinho, A., Alves, J. D., Torres, T., Drake, R. R., …, & Pinho, S. S. (2026). Glycome remodeling programs pathogenic γδ T17 cell responses in autoimmunity. Science Immunology. https://doi.org/10.1126/sciimmunol.aec9553

Vancouver

Santos-Pereira B, Nogueira R, Tafesse Y, Correia-Silva A, Leite-Gomes E, Sanchez Sanchez G, et al. Glycome remodeling programs pathogenic γδ T17 cell responses in autoimmunity. Science Immunology. 2026. doi:10.1126/sciimmunol.aec9553

BibTeX
@article{SantosPereira2026,
  author = {Santos-Pereira, Beatriz and Nogueira, Rafaela and Tafesse, Yohannes and Correia-Silva, Ariana and Leite-Gomes, Eduarda and Sanchez Sanchez, Guillem and Luppens, Xavier and Young, Lyndsay E A and Cavadas, Bruno and Vasconcelos, Carlos and Oliveira, Daniela and Lé, Ana and Torres, Joana and Campar, Ana and Serodio, João F and Marinho, António and Alves, José D and Torres, Tiago and Drake, Richard R and Vermijlen, David and Alves, Inês and Pinho, Salomé S},
  title = {Glycome remodeling programs pathogenic γδ T17 cell responses in autoimmunity},
  journal = {Science Immunology},
  year = {2026},
  doi = {10.1126/sciimmunol.aec9553}
}
Kostenlos starten →